# Is selank legal? What regulators have said

> No regulator document found approves selank. What FDA, Health Canada and New Zealand's Medsafe have said about selling, importing and holding it.

Source page: https://peptioresearch.com/articles/is-selank-legal/
Publisher: Peptio Research. Educational summary of published research, not medical advice.
Last checked against its sources: 2026-10-23
Type: Safety

No regulator document found for this page says selank is approved anywhere. Health Canada has named selank in two seizure advisories and said that selling the seized products is illegal in Canada. New Zealand's Medsafe names a product it spells "sealank" among peptides advertised by online sellers, under a heading saying it is illegal to import, sell or use "these products", and states a general rule that importing, supplying, possessing or procuring prescription medicines without authorisation is unlawful. In the United States, FDA once placed selank in a category of compounding substances with "significant safety risks"; the nomination was later withdrawn, and FDA's Import Alert 66-41 does not name selank. For the United Kingdom, Australia, the European Union and anti-doping rules, nothing was established. An absence of a statement is neither permission nor a ban. The law differs by country, and this page reports what each authority has published, not legal advice.

Four questions are easy to blur, and the sections below keep them apart: whether a product is approved, whether selling or supplying it is unlawful, whether importing it is unlawful, and whether holding it is. What has been studied about selank itself is on the selank page.

## United States

No FDA approval of selank was found. FDA's page on bulk drug substances that may present significant safety risks, current as of 22 April 2026, lists "Selank acetate (TP-7)" in a table of substances nominated but withdrawn [1]. It says that "Compounded drugs containing selank acetate may pose risk for immunogenicity for certain routes of administration" "due to the potential for aggregation and peptide-related impurities", and that "FDA lacks important information regarding any safety issues raised by selank acetate administered to humans" [1]. Immunogenicity is the potential to provoke an immune response.

The compounding history is in two of FDA's lists for 503A pharmacies, the pharmacies that compound for individual patients. The list of 29 September 2023 added "Selank Acetate (TP-7)" to category 2, under the words "FDA has identified significant safety risks with these substances" [2]. The copy of that list used here is hosted by the Alliance for Pharmacy Compounding, not by FDA. By the list updated 14 May 2026, selank had no entry in any category [3]. FDA's safety-risks page explains its withdrawn table: these substances were "previously in category 2 of the interim policies" and "were withdrawn by the nominators" [1]. So selank left category 2 because its nomination was withdrawn, not because FDA said its safety view had changed, and the page still prints the risk text. No FDA document found gives the date of the withdrawal or the reason.

FDA's Import Alert 66-41, on unapproved new drugs promoted in the US, was searched and no mention of selank was found [4]. That is an absence in what was checked, not proof of absence. No FDA document opened addresses possession.

## Canada

Health Canada has named selank in two advisories about seized products. One, originally published on 1 April 2025, lists "Selank" among the products seized, says "Health Canada has not authorized any of the products seized", and says "they are illegal to be sold in Canada." [5] The other, of 1 August 2025, lists "Selank" under "Unauthorized injectable peptide drugs", says "Health Canada has not authorized any of the products that were seized or sold on the company's website", and states: "Selling unauthorized drugs is illegal in Canada." [6] That list is headed "injectable", but it gives no form for selank, and this page does not say what form the seized selank took.

Both advisories say "Do not buy or use unauthorized drugs". That is advice; neither says that buying is an offence [5] [6]. A separate Health Canada advisory of 9 April 2026, which does not name selank, says Health Canada is working "with the Canada Border Services Agency to stop unauthorized shipments from entering the country", and that research-use labelling "does not make these products legal or exempt from regulatory requirements" [7]. That is a general enforcement statement, not a statement that importing selank for personal use is an offence. No Health Canada document found addresses possessing or personally importing selank.

## New Zealand

A Medsafe advisory published on 21 May 2026, in a section headed "Illegal products being promoted online", says that online sellers commonly advertise products including "melanotan II, retatrutide, sealank, seamax, TB-500 and thymosin", and that "This is not a complete list" [8]. Medsafe spells it "sealank"; reading that as selank is this site's inference.

The next heading reads "It is illegal to import, sell, or use these products". The advisory does not define "these products". Under that heading it says that "Under the Medicines Act 1981, many peptide products and SARMs are prescription medicines", that "It is unlawful to import, supply, possess or procure prescription medicines unless this is authorised.", and that "Products sold outside the regulated medicines system are illegal regardless of how they are labelled or marketed." [8]

The possession sentence is a general rule. It applies to prescription medicines, and the advisory says "many peptide products" are prescription medicines; it does not say selank is one, and this page does not call selank a prescription medicine in New Zealand. Even so, it is the only authority document found for this page that addresses importing and possession together.

## Russia

Selank is often described as a medicine registered in Russia. That was not confirmed from a Russian document. A 2022 narrative review lists selank among peptide drugs developed in Russia, in the "Anxiolytic" group, and says "14 products are registered in the Russian Federation" [9]. It gives no registration number, date, holder or prescription status. The Russian State Register of medicines returned only a captcha when searched for this page, so whether selank is currently registered there, and on what terms, is not established.

> **Key point.**
> Not approved, illegal to sell, illegal to import and illegal to possess are four different statements. Health Canada makes the first two about the selank it seized. Medsafe's heading calls the advertised products illegal to import, sell or use, and its possession rule is a general one for prescription medicines, without saying selank is one. FDA's documents found list selank's withdrawn compounding nomination and its safety concerns, and say nothing about selling or holding it by name.

## Countries not covered

No document from the UK's MHRA naming selank was found, and a search of gov.uk returned no results. The TGA's website could not be reached from the environment used to research this page, and no document naming selank in Australia's Poisons Standard was found, so this page does not state any Australian schedule. The European Medicines Agency's site search could not be used, and no EMA or national EU agency document naming selank was found. None of this means selank is legal in those places. No authority document found here supports a statement that selank is legal to buy for research purposes.

## Sport

Selank's status under anti-doping rules was not established from a primary document; the World Anti-Doping Agency's prohibited list could not be retrieved. A 2025 review, which is a second-hand source, placed selank in its table of substances with "unclear" status, those that "could not be directly assigned to the prohibited or non-prohibited group" [10].

## Sources

1. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. U.S. Food and Drug Administration. 2026. https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
2. Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act (Updated September 29, 2023). U.S. Food and Drug Administration (copy hosted by the Alliance for Pharmacy Compounding). 2023. https://join.a4pc.org/hubfs/PDFs/503A-Categories-Update-for-September-2023-FINAL.docx.pdf
3. Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act, updated May 14, 2026. U.S. Food and Drug Administration. 2026. https://www.fda.gov/media/94155/download
4. Import Alert 66-41: Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.. U.S. Food and Drug Administration. 2026. https://www.accessdata.fda.gov/cms_ia/importalert_190.html
5. Unauthorized injectable peptide drugs seized from Optimum Wellness Centre in Calgary, Alberta may pose serious health risks. Health Canada (Recalls and safety alerts). 2025. https://recalls-rappels.canada.ca/en/alert-recall/unauthorized-injectable-peptide-drugs-seized-optimum-wellness-centre-calgary-alberta
6. Unauthorized injectable peptide drugs seized and sold by Canada Peptide may pose serious health risks. Health Canada (Recalls and safety alerts). 2025. https://recalls-rappels.canada.ca/en/alert-recall/unauthorized-injectable-peptide-drugs-seized-and-sold-canada-peptide-may-pose-serious
7. Think twice before injecting peptides bought online: unauthorized products can seriously harm your health. Health Canada (Recalls and safety alerts). 2026. https://recalls-rappels.canada.ca/en/alert-recall/think-twice-injecting-peptides-bought-online-unauthorized-products-can-seriously-harm
8. Consumer advisory: Unapproved peptide products health warning. Medsafe (New Zealand Medicines and Medical Devices Safety Authority). 2026. https://medsafe.govt.nz/Safety/Alerts/Consumer-advisory-Unapproved-peptide-products-health-warning.asp
9. Deigin VI et al. Development of Peptide Biopharmaceuticals in Russia. Pharmaceutics. 2022. https://doi.org/10.3390/pharmaceutics14040716
10. Pokrywka A et al. "Brain doping" substances: prohibited or not in sports?. Biology of Sport. 2025. https://doi.org/10.5114/biolsport.2025.150047
